Home > Products > API > Lorlatinib(PF0643922)
Lorlatinib(PF0643922)
  • Lorlatinib(PF0643922)Lorlatinib(PF0643922)

Lorlatinib(PF0643922)

Product Name:Lorlatinib(PF0643922)
Formulae hypotheticae: C21H19FN6O2
M. Pondus: 406.41
CAS Subcriptio Number; 1454846-35-5

Model:CAS NO:1454846-35-5

Mitte Inquisitionem

depictio producti

Lorlatinib(PF0643922)

Product nomen:Lorlatinib(PF0643922) 1454846-35-5
CAS No:1454846-35-5
Specification: in domo

Nomen Lorlatinib(PF0643922)
Synonyma PF0643922; PF-06463922;(10R)-7-Amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-2H-4,8-methenopyrazolo[4; 3-h][2,5,11] benzoxadiazacyclotetradecine-3-carbonitrile;Lorlatinib,PF-Chemica albook06463922; PF-06463922, Lorlatinib;(R)-26-amino-55-fluoro-11,4,7-trimethyl-6-oxo-11H-3-oxa-7-aza-2(3,5)-pyridina. -1(4,3)-pyrazola-5(1,2)-benzenacyclooctaphane-15-carbonitrile;EOS 60936; Loratinib
copyRight
M. Structure CAS # 59-02-9, Vitamin E, D-alpha-Tocopherol, (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
Formulae hypotheticae C21H19FN6O2
M. Pondus 406.41
CAS Subcriptio Number 1454846-35-5


Tractantem et repono
Cautiones pro tutum pertractatio
Bene ventilatas tractantem in loco. Apta tutela vestitus. Pelle et oculis contactum fuge. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Conditiones repono pro tuto, inter quaslibet incompatibilitates
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.

Imprimis usus finis (s): oeconomiae laboratoriae, ad investigationes scientificas et evolutionem tantum



Hot Tags: Lorlatinib(PF0643922), China, Suppliers, Fabrica, Factory
Related Categoria
Mitte Inquisitionem
Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept